Skip to main content

Blog

Solid Biosciences Shares Update on INSPIRE DUCHENNE Trial of SGT-003

...

Calling All Adults with Duchenne & Becker: Join the 2026 PPMD Adult Advisory Committee (PAAC)

...

Dyne Therapeutics, Inc. announced today FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy

...

Watch: Capricor Therapeutics – Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy

...

Sarepta to Resume ELEVIDYS Shipments to Ambulatory Patients After FDA Recommends Removal of Voluntary Hold for Ambulatory Population

...

FDA Grants Breakthrough Therapy Designation to Avidity’s del-zota

...

Update on ELEVIDYS Shipments in the U.S.

...

ELEVIDYS Update

...

Sarepta Therapeutics Announces Update on ELEVIDYS Label, Company Restructuring

...

Post AAV Gene Therapy Resources

...